Health
DiosCURE to Develop Highly Specific Single-Chain Antibodies Against SARS-CoV-2, Lead Candidates Described in Science Publication | Antibodies | News Channels – PipelineReview.com
La Merie Publishing prepares brief and full reports as well as competitor analysis reports, the latter in a tabulated format with structured listings of industry-relevant…
Details
Category: Antibodies
Published on Tuesday, 12 January 2021 16:21
Hits: 125
– Core technology includes promising bivalent single-domain antibodies simultaneously targeting two surface structures of the viral spike protein.
– Lead candidates DIOS-202 and DIOS-203 are engineered for high potency and their potential to avoid the emergence of escape mutants.
– DIOS-202 and DIOS-203 entered into accelerated development to initiate clinical studies later this year.
BONN, Germany I January 12,…
-
Noosa News8 hours agoHow Lily Steele-Park took her rapist to court and won
-
General22 hours ago‘Potential’ hacker contacts Qantas over data breach
-
Business13 hours agoFord CEO makes stunning prediction about artificial intelligence
-
General24 hours agoFears for next anti-Semitic firebombing on home soil